nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroflumethiazide—Cutaneous vasculitis—Tamoxifen—pancreatic cancer	0.0545	0.0816	CcSEcCtD
Hydroflumethiazide—CA9—gall bladder—pancreatic cancer	0.0371	0.127	CbGeAlD
Hydroflumethiazide—KCNMA1—gall bladder—pancreatic cancer	0.0286	0.0976	CbGeAlD
Hydroflumethiazide—CA9—islet of Langerhans—pancreatic cancer	0.0243	0.0829	CbGeAlD
Hydroflumethiazide—KCNMA1—islet of Langerhans—pancreatic cancer	0.0188	0.064	CbGeAlD
Hydroflumethiazide—ATP1A1—gall bladder—pancreatic cancer	0.0184	0.0627	CbGeAlD
Hydroflumethiazide—CA7—digestive system—pancreatic cancer	0.0166	0.0567	CbGeAlD
Hydroflumethiazide—CA9—digestive system—pancreatic cancer	0.0146	0.0498	CbGeAlD
Hydroflumethiazide—Vasculitis—Tamoxifen—pancreatic cancer	0.0146	0.0218	CcSEcCtD
Hydroflumethiazide—CA2—gall bladder—pancreatic cancer	0.0141	0.048	CbGeAlD
Hydroflumethiazide—KCNMA1—pancreas—pancreatic cancer	0.0132	0.045	CbGeAlD
Hydroflumethiazide—Hyperuricaemia—Sunitinib—pancreatic cancer	0.0131	0.0197	CcSEcCtD
Hydroflumethiazide—Blood uric acid increased—Sunitinib—pancreatic cancer	0.0124	0.0186	CcSEcCtD
Hydroflumethiazide—ATP1A1—islet of Langerhans—pancreatic cancer	0.0121	0.0411	CbGeAlD
Hydroflumethiazide—CA5B—pancreas—pancreatic cancer	0.0114	0.0387	CbGeAlD
Hydroflumethiazide—CA4—islet of Langerhans—pancreatic cancer	0.0111	0.038	CbGeAlD
Hydroflumethiazide—CA12—digestive system—pancreatic cancer	0.0108	0.0368	CbGeAlD
Hydroflumethiazide—CA1—pancreas—pancreatic cancer	0.01	0.0342	CbGeAlD
Hydroflumethiazide—Vasculitis—Gemcitabine—pancreatic cancer	0.01	0.015	CcSEcCtD
Hydroflumethiazide—Cramp muscle—Tamoxifen—pancreatic cancer	0.0093	0.0139	CcSEcCtD
Hydroflumethiazide—CA2—islet of Langerhans—pancreatic cancer	0.00924	0.0315	CbGeAlD
Hydroflumethiazide—Pancreatitis—Tamoxifen—pancreatic cancer	0.00875	0.0131	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Erlotinib—pancreatic cancer	0.00865	0.013	CcSEcCtD
Hydroflumethiazide—CA1—digestive system—pancreatic cancer	0.00856	0.0292	CbGeAlD
Hydroflumethiazide—ATP1A1—pancreas—pancreatic cancer	0.00848	0.0289	CbGeAlD
Hydroflumethiazide—Photosensitivity—Fluorouracil—pancreatic cancer	0.00794	0.0119	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Sunitinib—pancreatic cancer	0.00749	0.0112	CcSEcCtD
Hydroflumethiazide—ATP1A1—digestive system—pancreatic cancer	0.00724	0.0247	CbGeAlD
Hydroflumethiazide—Hyperglycaemia—Sunitinib—pancreatic cancer	0.00689	0.0103	CcSEcCtD
Hydroflumethiazide—CA4—digestive system—pancreatic cancer	0.00669	0.0228	CbGeAlD
Hydroflumethiazide—Orthostatic hypotension—Irinotecan—pancreatic cancer	0.00665	0.00997	CcSEcCtD
Hydroflumethiazide—Cramp muscle—Irinotecan—pancreatic cancer	0.00656	0.00983	CcSEcCtD
Hydroflumethiazide—CA2—pancreas—pancreatic cancer	0.0065	0.0221	CbGeAlD
Hydroflumethiazide—Pancreatitis—Irinotecan—pancreatic cancer	0.00617	0.00925	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Tamoxifen—pancreatic cancer	0.00598	0.00896	CcSEcCtD
Hydroflumethiazide—Glycosuria—Epirubicin—pancreatic cancer	0.00577	0.00865	CcSEcCtD
Hydroflumethiazide—Leukopenia—Tamoxifen—pancreatic cancer	0.00556	0.00834	CcSEcCtD
Hydroflumethiazide—CA2—digestive system—pancreatic cancer	0.00555	0.0189	CbGeAlD
Hydroflumethiazide—Hyperglycaemia—Gemcitabine—pancreatic cancer	0.00553	0.00829	CcSEcCtD
Hydroflumethiazide—Photosensitivity reaction—Fluorouracil—pancreatic cancer	0.0055	0.00824	CcSEcCtD
Hydroflumethiazide—Jaundice—Irinotecan—pancreatic cancer	0.00547	0.0082	CcSEcCtD
Hydroflumethiazide—Glycosuria—Doxorubicin—pancreatic cancer	0.00534	0.00801	CcSEcCtD
Hydroflumethiazide—Jaundice cholestatic—Epirubicin—pancreatic cancer	0.00532	0.00798	CcSEcCtD
Hydroflumethiazide—ATP1A1—Ion transport by P-type ATPases—FXYD3—pancreatic cancer	0.00518	0.132	CbGpPWpGaD
Hydroflumethiazide—Muscle spasms—Sunitinib—pancreatic cancer	0.00512	0.00767	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Gemcitabine—pancreatic cancer	0.0051	0.00764	CcSEcCtD
Hydroflumethiazide—Hyperuricaemia—Epirubicin—pancreatic cancer	0.00504	0.00756	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Fluorouracil—pancreatic cancer	0.00502	0.00752	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Tamoxifen—pancreatic cancer	0.00497	0.00744	CcSEcCtD
Hydroflumethiazide—Jaundice cholestatic—Doxorubicin—pancreatic cancer	0.00493	0.00738	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Erlotinib—pancreatic cancer	0.00491	0.00736	CcSEcCtD
Hydroflumethiazide—Anorexia—Tamoxifen—pancreatic cancer	0.00484	0.00725	CcSEcCtD
Hydroflumethiazide—Anorexia—Erlotinib—pancreatic cancer	0.00478	0.00717	CcSEcCtD
Hydroflumethiazide—Leukopenia—Sunitinib—pancreatic cancer	0.00477	0.00714	CcSEcCtD
Hydroflumethiazide—Blood uric acid increased—Epirubicin—pancreatic cancer	0.00476	0.00714	CcSEcCtD
Hydroflumethiazide—Hyperuricaemia—Doxorubicin—pancreatic cancer	0.00467	0.00699	CcSEcCtD
Hydroflumethiazide—Orthostatic hypotension—Docetaxel—pancreatic cancer	0.0046	0.00689	CcSEcCtD
Hydroflumethiazide—Cramp muscle—Docetaxel—pancreatic cancer	0.00453	0.00679	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Tamoxifen—pancreatic cancer	0.00441	0.00661	CcSEcCtD
Hydroflumethiazide—Blood uric acid increased—Doxorubicin—pancreatic cancer	0.00441	0.0066	CcSEcCtD
Hydroflumethiazide—Aplastic anaemia—Epirubicin—pancreatic cancer	0.00439	0.00658	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Erlotinib—pancreatic cancer	0.00436	0.00654	CcSEcCtD
Hydroflumethiazide—Constipation—Tamoxifen—pancreatic cancer	0.00434	0.0065	CcSEcCtD
Hydroflumethiazide—Constipation—Erlotinib—pancreatic cancer	0.00429	0.00643	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Sunitinib—pancreatic cancer	0.00425	0.00637	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Irinotecan—pancreatic cancer	0.00422	0.00632	CcSEcCtD
Hydroflumethiazide—Anorexia—Sunitinib—pancreatic cancer	0.00414	0.00621	CcSEcCtD
Hydroflumethiazide—Aplastic anaemia—Doxorubicin—pancreatic cancer	0.00406	0.00609	CcSEcCtD
Hydroflumethiazide—Urticaria—Tamoxifen—pancreatic cancer	0.00403	0.00604	CcSEcCtD
Hydroflumethiazide—Vertigo—Irinotecan—pancreatic cancer	0.00394	0.0059	CcSEcCtD
Hydroflumethiazide—Leukopenia—Irinotecan—pancreatic cancer	0.00393	0.00588	CcSEcCtD
Hydroflumethiazide—Photosensitivity—Epirubicin—pancreatic cancer	0.00387	0.00579	CcSEcCtD
Hydroflumethiazide—Leukopenia—Gemcitabine—pancreatic cancer	0.00382	0.00573	CcSEcCtD
Hydroflumethiazide—Vascular purpura—Epirubicin—pancreatic cancer	0.0038	0.00569	CcSEcCtD
Hydroflumethiazide—Jaundice—Docetaxel—pancreatic cancer	0.00378	0.00567	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Sunitinib—pancreatic cancer	0.00378	0.00566	CcSEcCtD
Hydroflumethiazide—Leukopenia—Fluorouracil—pancreatic cancer	0.00376	0.00563	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00374	0.0056	CcSEcCtD
Hydroflumethiazide—Constipation—Sunitinib—pancreatic cancer	0.00372	0.00557	CcSEcCtD
Hydroflumethiazide—Asthenia—Tamoxifen—pancreatic cancer	0.00364	0.00545	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Docetaxel—pancreatic cancer	0.00362	0.00542	CcSEcCtD
Hydroflumethiazide—Asthenia—Erlotinib—pancreatic cancer	0.0036	0.0054	CcSEcCtD
Hydroflumethiazide—Photosensitivity—Doxorubicin—pancreatic cancer	0.00358	0.00536	CcSEcCtD
Hydroflumethiazide—Purpura—Epirubicin—pancreatic cancer	0.00352	0.00528	CcSEcCtD
Hydroflumethiazide—Vascular purpura—Doxorubicin—pancreatic cancer	0.00351	0.00526	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Irinotecan—pancreatic cancer	0.0035	0.00525	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Tamoxifen—pancreatic cancer	0.00347	0.0052	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Erlotinib—pancreatic cancer	0.00343	0.00515	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.00341	0.00512	CcSEcCtD
Hydroflumethiazide—Anorexia—Irinotecan—pancreatic cancer	0.00341	0.00511	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.00336	0.00503	CcSEcCtD
Hydroflumethiazide—Dizziness—Tamoxifen—pancreatic cancer	0.00336	0.00503	CcSEcCtD
Hydroflumethiazide—Anorexia—Gemcitabine—pancreatic cancer	0.00332	0.00498	CcSEcCtD
Hydroflumethiazide—Dizziness—Erlotinib—pancreatic cancer	0.00332	0.00497	CcSEcCtD
Hydroflumethiazide—Anorexia—Fluorouracil—pancreatic cancer	0.00327	0.0049	CcSEcCtD
Hydroflumethiazide—Purpura—Doxorubicin—pancreatic cancer	0.00326	0.00488	CcSEcCtD
Hydroflumethiazide—Vomiting—Tamoxifen—pancreatic cancer	0.00323	0.00483	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Sunitinib—pancreatic cancer	0.0032	0.0048	CcSEcCtD
Hydroflumethiazide—Rash—Tamoxifen—pancreatic cancer	0.0032	0.00479	CcSEcCtD
Hydroflumethiazide—Dermatitis—Tamoxifen—pancreatic cancer	0.0032	0.00479	CcSEcCtD
Hydroflumethiazide—Vomiting—Erlotinib—pancreatic cancer	0.00319	0.00478	CcSEcCtD
Hydroflumethiazide—Headache—Tamoxifen—pancreatic cancer	0.00318	0.00476	CcSEcCtD
Hydroflumethiazide—Rash—Erlotinib—pancreatic cancer	0.00316	0.00474	CcSEcCtD
Hydroflumethiazide—Dermatitis—Erlotinib—pancreatic cancer	0.00316	0.00474	CcSEcCtD
Hydroflumethiazide—Headache—Erlotinib—pancreatic cancer	0.00314	0.00471	CcSEcCtD
Hydroflumethiazide—Asthenia—Sunitinib—pancreatic cancer	0.00312	0.00467	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Irinotecan—pancreatic cancer	0.00311	0.00466	CcSEcCtD
Hydroflumethiazide—Orthostatic hypotension—Epirubicin—pancreatic cancer	0.0031	0.00465	CcSEcCtD
Hydroflumethiazide—Constipation—Irinotecan—pancreatic cancer	0.00306	0.00459	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Gemcitabine—pancreatic cancer	0.00303	0.00454	CcSEcCtD
Hydroflumethiazide—Nausea—Tamoxifen—pancreatic cancer	0.00301	0.00452	CcSEcCtD
Hydroflumethiazide—Constipation—Gemcitabine—pancreatic cancer	0.00298	0.00447	CcSEcCtD
Hydroflumethiazide—Nausea—Erlotinib—pancreatic cancer	0.00298	0.00447	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Fluorouracil—pancreatic cancer	0.00298	0.00447	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Sunitinib—pancreatic cancer	0.00297	0.00445	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Docetaxel—pancreatic cancer	0.00291	0.00437	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Epirubicin—pancreatic cancer	0.00288	0.00431	CcSEcCtD
Hydroflumethiazide—Dizziness—Sunitinib—pancreatic cancer	0.00287	0.00431	CcSEcCtD
Hydroflumethiazide—Orthostatic hypotension—Doxorubicin—pancreatic cancer	0.00287	0.0043	CcSEcCtD
Hydroflumethiazide—Vomiting—Sunitinib—pancreatic cancer	0.00276	0.00414	CcSEcCtD
Hydroflumethiazide—Rash—Sunitinib—pancreatic cancer	0.00274	0.00411	CcSEcCtD
Hydroflumethiazide—Dermatitis—Sunitinib—pancreatic cancer	0.00274	0.0041	CcSEcCtD
Hydroflumethiazide—Urticaria—Fluorouracil—pancreatic cancer	0.00272	0.00408	CcSEcCtD
Hydroflumethiazide—Headache—Sunitinib—pancreatic cancer	0.00272	0.00408	CcSEcCtD
Hydroflumethiazide—Leukopenia—Docetaxel—pancreatic cancer	0.00271	0.00407	CcSEcCtD
Hydroflumethiazide—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.00268	0.00401	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Doxorubicin—pancreatic cancer	0.00266	0.00399	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Epirubicin—pancreatic cancer	0.00265	0.00397	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Irinotecan—pancreatic cancer	0.00264	0.00395	CcSEcCtD
Hydroflumethiazide—Nausea—Sunitinib—pancreatic cancer	0.00258	0.00387	CcSEcCtD
Hydroflumethiazide—Asthenia—Irinotecan—pancreatic cancer	0.00257	0.00385	CcSEcCtD
Hydroflumethiazide—Jaundice—Epirubicin—pancreatic cancer	0.00255	0.00382	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00253	0.00378	CcSEcCtD
Hydroflumethiazide—Asthenia—Gemcitabine—pancreatic cancer	0.0025	0.00375	CcSEcCtD
Hydroflumethiazide—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.00248	0.00371	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.00245	0.00367	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Irinotecan—pancreatic cancer	0.00245	0.00367	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Epirubicin—pancreatic cancer	0.00244	0.00366	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Docetaxel—pancreatic cancer	0.00242	0.00363	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Gemcitabine—pancreatic cancer	0.00239	0.00357	CcSEcCtD
Hydroflumethiazide—Dizziness—Irinotecan—pancreatic cancer	0.00237	0.00355	CcSEcCtD
Hydroflumethiazide—Jaundice—Doxorubicin—pancreatic cancer	0.00236	0.00354	CcSEcCtD
Hydroflumethiazide—Anorexia—Docetaxel—pancreatic cancer	0.00236	0.00353	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Fluorouracil—pancreatic cancer	0.00235	0.00351	CcSEcCtD
Hydroflumethiazide—Vomiting—Irinotecan—pancreatic cancer	0.00228	0.00341	CcSEcCtD
Hydroflumethiazide—Dizziness—Fluorouracil—pancreatic cancer	0.00227	0.0034	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Doxorubicin—pancreatic cancer	0.00226	0.00339	CcSEcCtD
Hydroflumethiazide—Rash—Irinotecan—pancreatic cancer	0.00226	0.00338	CcSEcCtD
Hydroflumethiazide—Dermatitis—Irinotecan—pancreatic cancer	0.00225	0.00338	CcSEcCtD
Hydroflumethiazide—Headache—Irinotecan—pancreatic cancer	0.00224	0.00336	CcSEcCtD
Hydroflumethiazide—Vomiting—Gemcitabine—pancreatic cancer	0.00222	0.00332	CcSEcCtD
Hydroflumethiazide—Rash—Gemcitabine—pancreatic cancer	0.0022	0.00329	CcSEcCtD
Hydroflumethiazide—Dermatitis—Gemcitabine—pancreatic cancer	0.0022	0.00329	CcSEcCtD
Hydroflumethiazide—Headache—Gemcitabine—pancreatic cancer	0.00218	0.00327	CcSEcCtD
Hydroflumethiazide—Vomiting—Fluorouracil—pancreatic cancer	0.00218	0.00327	CcSEcCtD
Hydroflumethiazide—Rash—Fluorouracil—pancreatic cancer	0.00216	0.00324	CcSEcCtD
Hydroflumethiazide—Dermatitis—Fluorouracil—pancreatic cancer	0.00216	0.00324	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Docetaxel—pancreatic cancer	0.00215	0.00322	CcSEcCtD
Hydroflumethiazide—Headache—Fluorouracil—pancreatic cancer	0.00215	0.00322	CcSEcCtD
Hydroflumethiazide—Nausea—Irinotecan—pancreatic cancer	0.00213	0.00319	CcSEcCtD
Hydroflumethiazide—Constipation—Docetaxel—pancreatic cancer	0.00212	0.00317	CcSEcCtD
Hydroflumethiazide—Nausea—Gemcitabine—pancreatic cancer	0.00207	0.0031	CcSEcCtD
Hydroflumethiazide—Nausea—Fluorouracil—pancreatic cancer	0.00204	0.00305	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Epirubicin—pancreatic cancer	0.00197	0.00295	CcSEcCtD
Hydroflumethiazide—CA9—Regulation of gene expression by Hypoxia-inducible Factor—HIF1A—pancreatic cancer	0.00194	0.0497	CbGpPWpGaD
Hydroflumethiazide—Agitation—Epirubicin—pancreatic cancer	0.00188	0.00282	CcSEcCtD
Hydroflumethiazide—Vertigo—Epirubicin—pancreatic cancer	0.00184	0.00275	CcSEcCtD
Hydroflumethiazide—Leukopenia—Epirubicin—pancreatic cancer	0.00183	0.00274	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Docetaxel—pancreatic cancer	0.00182	0.00273	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Doxorubicin—pancreatic cancer	0.00182	0.00273	CcSEcCtD
Hydroflumethiazide—ATP1A1—Ion channel transport—FXYD3—pancreatic cancer	0.00179	0.0458	CbGpPWpGaD
Hydroflumethiazide—Asthenia—Docetaxel—pancreatic cancer	0.00178	0.00266	CcSEcCtD
Hydroflumethiazide—Agitation—Doxorubicin—pancreatic cancer	0.00174	0.00261	CcSEcCtD
Hydroflumethiazide—Vertigo—Doxorubicin—pancreatic cancer	0.0017	0.00255	CcSEcCtD
Hydroflumethiazide—Leukopenia—Doxorubicin—pancreatic cancer	0.00169	0.00254	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Docetaxel—pancreatic cancer	0.00169	0.00254	CcSEcCtD
Hydroflumethiazide—Dizziness—Docetaxel—pancreatic cancer	0.00164	0.00245	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Epirubicin—pancreatic cancer	0.00163	0.00245	CcSEcCtD
Hydroflumethiazide—Anorexia—Epirubicin—pancreatic cancer	0.00159	0.00238	CcSEcCtD
Hydroflumethiazide—Vomiting—Docetaxel—pancreatic cancer	0.00157	0.00236	CcSEcCtD
Hydroflumethiazide—Rash—Docetaxel—pancreatic cancer	0.00156	0.00234	CcSEcCtD
Hydroflumethiazide—Dermatitis—Docetaxel—pancreatic cancer	0.00156	0.00234	CcSEcCtD
Hydroflumethiazide—Headache—Docetaxel—pancreatic cancer	0.00155	0.00232	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.00151	0.00227	CcSEcCtD
Hydroflumethiazide—Anorexia—Doxorubicin—pancreatic cancer	0.00147	0.00221	CcSEcCtD
Hydroflumethiazide—Nausea—Docetaxel—pancreatic cancer	0.00147	0.0022	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Epirubicin—pancreatic cancer	0.00145	0.00217	CcSEcCtD
Hydroflumethiazide—Constipation—Epirubicin—pancreatic cancer	0.00143	0.00214	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Doxorubicin—pancreatic cancer	0.00134	0.00201	CcSEcCtD
Hydroflumethiazide—Urticaria—Epirubicin—pancreatic cancer	0.00133	0.00199	CcSEcCtD
Hydroflumethiazide—Constipation—Doxorubicin—pancreatic cancer	0.00132	0.00198	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Epirubicin—pancreatic cancer	0.00123	0.00184	CcSEcCtD
Hydroflumethiazide—Urticaria—Doxorubicin—pancreatic cancer	0.00123	0.00184	CcSEcCtD
Hydroflumethiazide—KCNMA1—Platelet homeostasis—PPP2R5B—pancreatic cancer	0.00121	0.031	CbGpPWpGaD
Hydroflumethiazide—Asthenia—Epirubicin—pancreatic cancer	0.0012	0.00179	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Epirubicin—pancreatic cancer	0.00114	0.00171	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Doxorubicin—pancreatic cancer	0.00114	0.0017	CcSEcCtD
Hydroflumethiazide—CA9—HIF-1-alpha transcription factor network—NDRG1—pancreatic cancer	0.00112	0.0285	CbGpPWpGaD
Hydroflumethiazide—Asthenia—Doxorubicin—pancreatic cancer	0.00111	0.00166	CcSEcCtD
Hydroflumethiazide—Dizziness—Epirubicin—pancreatic cancer	0.0011	0.00165	CcSEcCtD
Hydroflumethiazide—SLC12A1—SLC-mediated transmembrane transport—SLC29A1—pancreatic cancer	0.0011	0.0282	CbGpPWpGaD
Hydroflumethiazide—Vomiting—Epirubicin—pancreatic cancer	0.00106	0.00159	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Doxorubicin—pancreatic cancer	0.00106	0.00158	CcSEcCtD
Hydroflumethiazide—Rash—Epirubicin—pancreatic cancer	0.00105	0.00158	CcSEcCtD
Hydroflumethiazide—Dermatitis—Epirubicin—pancreatic cancer	0.00105	0.00158	CcSEcCtD
Hydroflumethiazide—Headache—Epirubicin—pancreatic cancer	0.00105	0.00157	CcSEcCtD
Hydroflumethiazide—CA9—Regulation of gene expression by Hypoxia-inducible Factor—VEGFA—pancreatic cancer	0.00102	0.0262	CbGpPWpGaD
Hydroflumethiazide—Dizziness—Doxorubicin—pancreatic cancer	0.00102	0.00153	CcSEcCtD
Hydroflumethiazide—SLC12A3—SLC-mediated transmembrane transport—SLC29A1—pancreatic cancer	0.001	0.0256	CbGpPWpGaD
Hydroflumethiazide—Nausea—Epirubicin—pancreatic cancer	0.000991	0.00149	CcSEcCtD
Hydroflumethiazide—Vomiting—Doxorubicin—pancreatic cancer	0.000982	0.00147	CcSEcCtD
Hydroflumethiazide—Rash—Doxorubicin—pancreatic cancer	0.000974	0.00146	CcSEcCtD
Hydroflumethiazide—Dermatitis—Doxorubicin—pancreatic cancer	0.000973	0.00146	CcSEcCtD
Hydroflumethiazide—Headache—Doxorubicin—pancreatic cancer	0.000967	0.00145	CcSEcCtD
Hydroflumethiazide—Nausea—Doxorubicin—pancreatic cancer	0.000917	0.00137	CcSEcCtD
Hydroflumethiazide—CA9—Cellular response to hypoxia—HIF1A—pancreatic cancer	0.000858	0.0219	CbGpPWpGaD
Hydroflumethiazide—SLC12A1—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000687	0.0176	CbGpPWpGaD
Hydroflumethiazide—SLC12A3—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000624	0.0159	CbGpPWpGaD
Hydroflumethiazide—ATP1A1—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000624	0.0159	CbGpPWpGaD
Hydroflumethiazide—SLC12A1—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.00056	0.0143	CbGpPWpGaD
Hydroflumethiazide—ATP1A1—Preimplantation Embryo—CDH1—pancreatic cancer	0.000509	0.013	CbGpPWpGaD
Hydroflumethiazide—SLC12A3—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000509	0.013	CbGpPWpGaD
Hydroflumethiazide—ATP1A1—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000509	0.013	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Circadian rythm related genes—AHR—pancreatic cancer	0.000484	0.0124	CbGpPWpGaD
Hydroflumethiazide—CA9—HIF-1-alpha transcription factor network—SMAD4—pancreatic cancer	0.000483	0.0123	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular response to hypoxia—VEGFA—pancreatic cancer	0.000452	0.0116	CbGpPWpGaD
Hydroflumethiazide—CA1—C-MYB transcription factor network—HES1—pancreatic cancer	0.000442	0.0113	CbGpPWpGaD
Hydroflumethiazide—SLC12A1—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	0.000416	0.0106	CbGpPWpGaD
Hydroflumethiazide—CA9—HIF-1-alpha transcription factor network—TERT—pancreatic cancer	0.000413	0.0106	CbGpPWpGaD
Hydroflumethiazide—CA9—HIF-1-alpha transcription factor network—HIF1A—pancreatic cancer	0.000395	0.0101	CbGpPWpGaD
Hydroflumethiazide—SLC12A3—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	0.000378	0.00966	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Circadian rythm related genes—EZH2—pancreatic cancer	0.000365	0.00933	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—IFNA5—pancreatic cancer	0.000288	0.00736	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—PPP2R5B—pancreatic cancer	0.000272	0.00695	CbGpPWpGaD
Hydroflumethiazide—CA1—C-MYB transcription factor network—CDKN2A—pancreatic cancer	0.000265	0.00677	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Circadian rythm related genes—TYMS—pancreatic cancer	0.000264	0.00676	CbGpPWpGaD
Hydroflumethiazide—CA1—C-MYB transcription factor network—PTGS2—pancreatic cancer	0.000248	0.00633	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—HSPA1B—pancreatic cancer	0.000237	0.00606	CbGpPWpGaD
Hydroflumethiazide—CA1—C-MYB transcription factor network—CCND1—pancreatic cancer	0.000224	0.00572	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—EZH2—pancreatic cancer	0.000216	0.00552	CbGpPWpGaD
Hydroflumethiazide—SLC12A1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000212	0.00541	CbGpPWpGaD
Hydroflumethiazide—CA9—HIF-1-alpha transcription factor network—VEGFA—pancreatic cancer	0.000208	0.00532	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—PRSS1—pancreatic cancer	0.000203	0.00518	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—HSPA1A—pancreatic cancer	0.0002	0.00511	CbGpPWpGaD
Hydroflumethiazide—CA1—C-MYB transcription factor network—NRAS—pancreatic cancer	0.000193	0.00492	CbGpPWpGaD
Hydroflumethiazide—ATP1A1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000192	0.00491	CbGpPWpGaD
Hydroflumethiazide—SLC12A3—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000192	0.00491	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Circadian rythm related genes—PPARG—pancreatic cancer	0.000187	0.00479	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PRSS1—pancreatic cancer	0.000184	0.00471	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PRSS1—pancreatic cancer	0.000184	0.00471	CbGpPWpGaD
Hydroflumethiazide—CA1—C-MYB transcription factor network—MYC—pancreatic cancer	0.00018	0.00459	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—ARG2—pancreatic cancer	0.000176	0.00449	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PRSS1—pancreatic cancer	0.000171	0.00436	CbGpPWpGaD
Hydroflumethiazide—CA1—C-MYB transcription factor network—KRAS—pancreatic cancer	0.000166	0.00424	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—CD44—pancreatic cancer	0.000163	0.00416	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—ARG2—pancreatic cancer	0.00016	0.00408	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—ARG2—pancreatic cancer	0.00016	0.00408	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—IFNA1—pancreatic cancer	0.000158	0.00403	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—SOD2—pancreatic cancer	0.000155	0.00396	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—TYMP—pancreatic cancer	0.000153	0.00392	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—ARG2—pancreatic cancer	0.000148	0.00378	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—IFNA2—pancreatic cancer	0.000147	0.00375	CbGpPWpGaD
Hydroflumethiazide—CA1—C-MYB transcription factor network—HRAS—pancreatic cancer	0.000141	0.0036	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—TYMP—pancreatic cancer	0.00014	0.00357	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—TYMP—pancreatic cancer	0.00014	0.00357	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PRSS1—pancreatic cancer	0.000136	0.00348	CbGpPWpGaD
Hydroflumethiazide—CA9—HIF-1-alpha transcription factor network—AKT1—pancreatic cancer	0.000133	0.00339	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PRSS1—pancreatic cancer	0.000131	0.00333	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—HIF1A—pancreatic cancer	0.00013	0.00333	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—TYMP—pancreatic cancer	0.000129	0.00331	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Circadian rythm related genes—PTEN—pancreatic cancer	0.000129	0.00328	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PRSS1—pancreatic cancer	0.000125	0.0032	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—GLP1R—pancreatic cancer	0.000124	0.00316	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—DPYD—pancreatic cancer	0.000122	0.00311	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—ARG2—pancreatic cancer	0.000118	0.00302	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—SLC2A2—pancreatic cancer	0.000115	0.00295	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—ARG2—pancreatic cancer	0.000113	0.00289	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—GLP1R—pancreatic cancer	0.000113	0.00288	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—GLP1R—pancreatic cancer	0.000113	0.00288	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—DPYD—pancreatic cancer	0.000111	0.00283	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—DPYD—pancreatic cancer	0.000111	0.00283	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PRSS1—pancreatic cancer	0.00011	0.00281	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—ARG2—pancreatic cancer	0.000108	0.00277	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—RB1—pancreatic cancer	0.000106	0.00271	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—SLC2A2—pancreatic cancer	0.000105	0.00269	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—SLC2A2—pancreatic cancer	0.000105	0.00269	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—GLP1R—pancreatic cancer	0.000104	0.00266	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—PLAU—pancreatic cancer	0.000104	0.00266	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—TYMP—pancreatic cancer	0.000103	0.00264	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—DPYD—pancreatic cancer	0.000103	0.00262	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—TYMP—pancreatic cancer	9.89e-05	0.00253	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—SLC2A2—pancreatic cancer	9.73e-05	0.00249	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ARG2—pancreatic cancer	9.54e-05	0.00244	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—TYMP—pancreatic cancer	9.48e-05	0.00242	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—CDKN2A—pancreatic cancer	9.32e-05	0.00238	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—PIK3CG—pancreatic cancer	9.27e-05	0.00237	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—EGF—pancreatic cancer	9.17e-05	0.00234	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—CD44—pancreatic cancer	8.94e-05	0.00229	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Circadian rythm related genes—TP53—pancreatic cancer	8.77e-05	0.00224	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—GCG—pancreatic cancer	8.58e-05	0.00219	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—CXCL8—pancreatic cancer	8.45e-05	0.00216	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—TYMP—pancreatic cancer	8.34e-05	0.00213	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—GLP1R—pancreatic cancer	8.32e-05	0.00212	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—DPYD—pancreatic cancer	8.18e-05	0.00209	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—PIK3CD—pancreatic cancer	8.15e-05	0.00208	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—CD44—pancreatic cancer	8.14e-05	0.00208	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—CD44—pancreatic cancer	8.14e-05	0.00208	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—STK11—pancreatic cancer	8.06e-05	0.00206	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—GLP1R—pancreatic cancer	7.97e-05	0.00204	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—DPYD—pancreatic cancer	7.84e-05	0.002	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—GCG—pancreatic cancer	7.8e-05	0.00199	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—GCG—pancreatic cancer	7.8e-05	0.00199	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—SLC2A2—pancreatic cancer	7.76e-05	0.00198	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—GLP1R—pancreatic cancer	7.64e-05	0.00195	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—CD44—pancreatic cancer	7.54e-05	0.00193	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—DPYD—pancreatic cancer	7.52e-05	0.00192	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—SLC2A2—pancreatic cancer	7.44e-05	0.0019	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—STK11—pancreatic cancer	7.34e-05	0.00187	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—STK11—pancreatic cancer	7.34e-05	0.00187	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—GCG—pancreatic cancer	7.23e-05	0.00185	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—SLC2A2—pancreatic cancer	7.14e-05	0.00182	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—PIK3CB—pancreatic cancer	7.11e-05	0.00182	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—TYMS—pancreatic cancer	6.94e-05	0.00177	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—VEGFA—pancreatic cancer	6.86e-05	0.00175	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—STK11—pancreatic cancer	6.8e-05	0.00174	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—STAT3—pancreatic cancer	6.8e-05	0.00174	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—GLP1R—pancreatic cancer	6.72e-05	0.00172	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—DPYD—pancreatic cancer	6.61e-05	0.00169	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Neuronal System—HRAS—pancreatic cancer	6.45e-05	0.00165	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—TYMS—pancreatic cancer	6.31e-05	0.00161	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—TYMS—pancreatic cancer	6.31e-05	0.00161	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—SLC2A2—pancreatic cancer	6.27e-05	0.0016	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—CD44—pancreatic cancer	6.01e-05	0.00154	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—TYMS—pancreatic cancer	5.85e-05	0.00149	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—GCG—pancreatic cancer	5.76e-05	0.00147	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—CD44—pancreatic cancer	5.76e-05	0.00147	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—SRC—pancreatic cancer	5.69e-05	0.00145	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—APOE—pancreatic cancer	5.64e-05	0.00144	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—VEGFA—pancreatic cancer	5.55e-05	0.00142	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—GCG—pancreatic cancer	5.53e-05	0.00141	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—CD44—pancreatic cancer	5.53e-05	0.00141	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—NRAS—pancreatic cancer	5.48e-05	0.0014	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—STK11—pancreatic cancer	5.42e-05	0.00138	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—GCG—pancreatic cancer	5.3e-05	0.00135	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—STK11—pancreatic cancer	5.2e-05	0.00133	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—TP53—pancreatic cancer	5.19e-05	0.00133	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—APOE—pancreatic cancer	5.13e-05	0.00131	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—APOE—pancreatic cancer	5.13e-05	0.00131	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—PIK3CG—pancreatic cancer	5.09e-05	0.0013	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—TGFB1—pancreatic cancer	5.09e-05	0.0013	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—STK11—pancreatic cancer	4.98e-05	0.00127	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—PPARG—pancreatic cancer	4.91e-05	0.00126	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CD44—pancreatic cancer	4.86e-05	0.00124	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—APOE—pancreatic cancer	4.75e-05	0.00121	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—KRAS—pancreatic cancer	4.71e-05	0.0012	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—TYMS—pancreatic cancer	4.66e-05	0.00119	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—GCG—pancreatic cancer	4.66e-05	0.00119	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PIK3CG—pancreatic cancer	4.63e-05	0.00118	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PIK3CG—pancreatic cancer	4.63e-05	0.00118	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—PIK3CD—pancreatic cancer	4.48e-05	0.00114	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PPARG—pancreatic cancer	4.47e-05	0.00114	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PPARG—pancreatic cancer	4.47e-05	0.00114	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—TYMS—pancreatic cancer	4.47e-05	0.00114	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—STK11—pancreatic cancer	4.38e-05	0.00112	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—PIK3CA—pancreatic cancer	4.33e-05	0.00111	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PIK3CG—pancreatic cancer	4.29e-05	0.0011	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—TYMS—pancreatic cancer	4.28e-05	0.00109	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—TP53—pancreatic cancer	4.19e-05	0.00107	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PPARG—pancreatic cancer	4.14e-05	0.00106	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PIK3CD—pancreatic cancer	4.07e-05	0.00104	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PIK3CD—pancreatic cancer	4.07e-05	0.00104	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—HRAS—pancreatic cancer	4.01e-05	0.00102	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—PIK3CB—pancreatic cancer	3.9e-05	0.000997	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—PTGS2—pancreatic cancer	3.86e-05	0.000988	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—APOE—pancreatic cancer	3.79e-05	0.000969	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PIK3CD—pancreatic cancer	3.77e-05	0.000964	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—TYMS—pancreatic cancer	3.77e-05	0.000963	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—APOE—pancreatic cancer	3.63e-05	0.000929	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PIK3CB—pancreatic cancer	3.55e-05	0.000907	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PIK3CB—pancreatic cancer	3.55e-05	0.000907	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—AKT1—pancreatic cancer	3.54e-05	0.000904	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PTGS2—pancreatic cancer	3.52e-05	0.000898	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PTGS2—pancreatic cancer	3.52e-05	0.000898	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—APOE—pancreatic cancer	3.48e-05	0.00089	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PIK3CG—pancreatic cancer	3.42e-05	0.000874	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—PTEN—pancreatic cancer	3.37e-05	0.000861	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PPARG—pancreatic cancer	3.3e-05	0.000844	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PIK3CB—pancreatic cancer	3.29e-05	0.00084	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PIK3CG—pancreatic cancer	3.28e-05	0.000838	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PTGS2—pancreatic cancer	3.26e-05	0.000832	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PPARG—pancreatic cancer	3.17e-05	0.000809	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PIK3CG—pancreatic cancer	3.14e-05	0.000804	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PTEN—pancreatic cancer	3.07e-05	0.000784	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PTEN—pancreatic cancer	3.07e-05	0.000784	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—APOE—pancreatic cancer	3.06e-05	0.000783	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PPARG—pancreatic cancer	3.04e-05	0.000776	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PIK3CD—pancreatic cancer	3.01e-05	0.000769	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PIK3CD—pancreatic cancer	2.88e-05	0.000737	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PTEN—pancreatic cancer	2.84e-05	0.000726	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PIK3CG—pancreatic cancer	2.76e-05	0.000706	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PIK3CD—pancreatic cancer	2.76e-05	0.000706	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PPARG—pancreatic cancer	2.67e-05	0.000682	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PIK3CB—pancreatic cancer	2.62e-05	0.00067	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PTGS2—pancreatic cancer	2.6e-05	0.000664	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PIK3CB—pancreatic cancer	2.51e-05	0.000642	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PTGS2—pancreatic cancer	2.49e-05	0.000636	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PIK3CD—pancreatic cancer	2.43e-05	0.000621	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PIK3CB—pancreatic cancer	2.41e-05	0.000616	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PTGS2—pancreatic cancer	2.39e-05	0.00061	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—PIK3CA—pancreatic cancer	2.38e-05	0.000608	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PTEN—pancreatic cancer	2.27e-05	0.000579	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PTEN—pancreatic cancer	2.17e-05	0.000555	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PIK3CA—pancreatic cancer	2.16e-05	0.000553	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PIK3CA—pancreatic cancer	2.16e-05	0.000553	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PIK3CB—pancreatic cancer	2.12e-05	0.000541	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PTGS2—pancreatic cancer	2.1e-05	0.000536	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PTEN—pancreatic cancer	2.08e-05	0.000532	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PIK3CA—pancreatic cancer	2e-05	0.000512	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—AKT1—pancreatic cancer	1.94e-05	0.000496	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PTEN—pancreatic cancer	1.83e-05	0.000468	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—AKT1—pancreatic cancer	1.77e-05	0.000452	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—AKT1—pancreatic cancer	1.77e-05	0.000452	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—AKT1—pancreatic cancer	1.64e-05	0.000418	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PIK3CA—pancreatic cancer	1.6e-05	0.000408	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PIK3CA—pancreatic cancer	1.53e-05	0.000392	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PIK3CA—pancreatic cancer	1.47e-05	0.000375	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—AKT1—pancreatic cancer	1.31e-05	0.000334	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PIK3CA—pancreatic cancer	1.29e-05	0.00033	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—AKT1—pancreatic cancer	1.25e-05	0.00032	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—AKT1—pancreatic cancer	1.2e-05	0.000307	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—AKT1—pancreatic cancer	1.05e-05	0.00027	CbGpPWpGaD
